Compare ULBI & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ULBI | IXHL |
|---|---|---|
| Founded | 1990 | 2001 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | |
| Sector | Miscellaneous | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 105.7M | 97.6M |
| IPO Year | 1995 | 2024 |
| Metric | ULBI | IXHL |
|---|---|---|
| Price | $5.75 | $4.19 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 26.5K | ★ 6.5M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1166.67 | N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $164,456,000.00 | $12,000.00 |
| Revenue This Year | $31.30 | N/A |
| Revenue Next Year | $6.24 | N/A |
| P/E Ratio | $65.11 | ★ N/A |
| Revenue Growth | ★ 3.66 | N/A |
| 52 Week Low | $4.07 | $0.11 |
| 52 Week High | $9.51 | $1.66 |
| Indicator | ULBI | IXHL |
|---|---|---|
| Relative Strength Index (RSI) | 37.64 | 96.09 |
| Support Level | $5.42 | $0.32 |
| Resistance Level | $6.14 | N/A |
| Average True Range (ATR) | 0.27 | 0.09 |
| MACD | -0.07 | 0.25 |
| Stochastic Oscillator | 3.96 | 80.26 |
Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.